Last reviewed · How we verify
ZALTOPROFEN
At a glance
| Generic name | ZALTOPROFEN |
|---|---|
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Iris Vascular Area Density-Based Preoperative Pain-Risk Screening and Intervention in Second-Eye Cataract Surgery (PHASE4)
- ERAS Program Implementation for MIPD (NA)
- Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients (PHASE4)
- Nutraceutical Support With Omega-3 (NA)
- Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 (PHASE4)
- Observation on the Herpes Simplex Keratitis
- East-West Collaborative Medicine Using Bee-Venom Acupuncture on Whiplash-Associated Disorders (NA)
- The Effect of East-West Collaborative Medicine on Chronic Cervical Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ZALTOPROFEN CI brief — competitive landscape report
- ZALTOPROFEN updates RSS · CI watch RSS